血管内皮生长因子B(VEGFB)重组蛋白
Recombinant Vascular Endothelial Growth Factor B (VEGFB)
VEGF-B; VEGFL; VRF; VEGF-Related Factor
- 编号RPA144Hu01
- 物种Homo sapiens (Human，人)相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量23.2kDa
- 实际分子量27kDa(差异分析请参阅说明书)
- 片段与标签Pro22~Ala207 with N-terminal His Tag
- 缓冲液成份20mM Tris, 150mM NaCl缓冲液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性状冻干粉
- 纯度> 97%
- 等电点8.2
- 应用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载英文说明书 中文说明书
- 规格10µg50µg200µg1mg5mg
- 价格¥ 1008¥ 2520¥ 5040¥ 15120¥ 37800
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
Figure . Gene Sequencing (extract)
Figure. SDS-PAGE
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| RPA144Hu01 | 血管内皮生长因子B(VEGFB)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA144Hu01 | 血管内皮生长因子B(VEGFB)活性蛋白 | Cell culture; Activity Assays. |
| PAA144Hu01 | 血管内皮生长因子B(VEGFB)多克隆抗体 | IHC |
| LAA144Hu71 | 血管内皮生长因子B(VEGFB)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| LAA144Hu81 | 血管内皮生长因子B(VEGFB)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| MAA144Hu22 | 血管内皮生长因子B(VEGFB)单克隆抗体 | WB; IHC; ICC; IP. |
| LAA144Hu82 | 血管内皮生长因子B(VEGFB)单克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| LAA144Hu72 | 血管内皮生长因子B(VEGFB)单克隆抗体(生物素标记) | WB; IHC; ICC. |
| SEA144Hu | 血管内皮生长因子B(VEGFB)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA144Hu | 血管内皮生长因子B(VEGFB)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| International Journal of Cardiology | Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction.[PubMed: 22459379] |
| Applied Sciences-Basel | Assessment of annexin A5 and annexin A2 levels as biomarkers for pre-eclampsia: A pilot study[pubmed:29099033] |
| Journal of Endocrinological Investigation | Plasma vascular endothelial growth factor B levels are increased in patients with newly diagnosed type 2 diabetes mellitus and associated with the first phase of glucose-stimulated insulin secretion function of β-cell[10.1007/s40618-017-0677-z] |
| EXCLI Journal | Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction[] |
| Cancer Chemother Pharmacol | Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors[34164713] |